Pharmaceutical Exporter to South Korea from India
Indian Generic Medicines (IGM) is a WHO-GMP-aligned, DGFT-registered pharmaceutical exporter to South Korea from India — supplying generics, APIs, oncology and specialty products to licensed importers and partners, meeting MFDS quality expectations with full documentation.
India to South Korea: a reliable medicine-supply corridor
South Korea is a premium, quality-first pharmaceutical market with a stringent regulator (MFDS). India’s US-FDA and EU-GMP-approved facilities, plus strong API capabilities, make it a credible source for generics, APIs and specialty products. As a reliable pharmaceutical exporter to South Korea from India, Indian Generic Medicines (IGM) operates within this corridor with full MFDS-ready documentation, sourcing from facilities holding WHO-GMP, US FDA and EU-GMP certifications.
Key takeaways
- South Korea is a premium, quality-first market regulated by the MFDS — one of Asia’s most stringent, ICH-member authorities.
- Approval requires a detailed dossier, a DMF for APIs, and high-standard GMP verification.
- India’s US-FDA/EU-GMP-approved facilities and API strength suit MFDS expectations.
- A WHO-GMP/EU-GMP exporter provides COA, CPP, GMP certificate, DMF and Certificate of Origin.
- IGM supplies generics, APIs, oncology and specialty products to South Korea with full documentation.
Why South Korea sources pharmaceuticals from India
South Korea is a premium, quality-first pharmaceutical market with a stringent regulator (MFDS). India’s US-FDA and EU-GMP-approved facilities, plus strong API capabilities, make it a credible source for generics, APIs and specialty products.
What a pharmaceutical exporter to South Korea from India supplies
The range spans the therapeutic segments South Korea’s hospitals, distributors and pharmacies need most:
Indian Generic Medicines: a trusted export partner for South Korea
Buyers look for a proven track record, verifiable certifications and reliable supply. IGM delivers all three:
What South Korea requires from Indian exporters
South Korea’s medicines are regulated by the Ministry of Food and Drug Safety (MFDS) — one of Asia’s most stringent authorities and an ICH member. Product approval requires a detailed dossier, a Drug Master File (DMF) for APIs, and GMP compliance verified to a high standard. India’s US-FDA/EU-GMP-approved facilities are well placed to meet these expectations for generics, APIs and specialty products.
| Requirement / Document | Purpose |
|---|---|
| MFDS product registration | Required before a medicine can be marketed in South Korea. |
| Importer licence & import permit | Held by the South Korea partner to legally import and distribute. |
| Certificate of Analysis (COA) | Confirms quality and composition of each batch. |
| Certificate of Pharmaceutical Product (CPP) | Confirms the product’s regulatory status in India (WHO format). |
| GMP Certificate | Confirms the site meets Good Manufacturing Practice standards. |
| Certificate of Origin & commercial invoice | Required for customs clearance. |
In practice, the South Korea importer or distributor — not the Indian exporter — holds the MFDS licence and manages registration. IGM works closely with licensed local partners and provides all supplier-side documentation.
How to import medicine from India to South Korea — step by step
Who in South Korea should work with an Indian exporter
Source certified medicines from India for South Korea
Request a product catalogue, price and quotation. Share your therapeutic list, quantities and registration status — we’ll respond with MFDS-ready documentation and logistics options.
Frequently asked questions
The Ministry of Food and Drug Safety (MFDS) — a stringent, ICH-member regulator. Products require MFDS approval, a dossier, a DMF for APIs and high-standard GMP verification before import.
MFDS expects high-standard GMP, typically supported by US FDA or EU-GMP approval, ICH-compliant dossiers and a DMF for APIs. India’s internationally approved facilities are well placed to meet these.
The Korean importer must be licensed and hold MFDS approval for the product. The Indian exporter provides DGFT registration, WHO-GMP/EU-GMP sourcing, COA, CPP, GMP certificate, DMF and Certificate of Origin.
Generics, active pharmaceutical ingredients (APIs), oncology drugs and specialty products, subject to MFDS approval and destination requirements.
By sea to Busan or Incheon, roughly 2–4 weeks, or by air to Incheon International Airport, about 4–6 days. Cold-chain products ship temperature-monitored.
COA, CPP, GMP certificate, DMF (for APIs), Certificate of Origin, commercial invoice and packing list. MFDS approval is handled by the Korean importer using this documentation.
Your trusted medicine exporter from India to South Korea
As a DGFT-registered pharmaceutical exporter to South Korea from India, IGM supplies WHO-GMP-aligned generics, oncology drugs, antibiotics, antivirals, vaccines and injectables — each order backed by MFDS-compatible documentation and reliable logistics. Combining India’s certified manufacturing quality with a broad product range and dependable supply, IGM is built to serve importers, hospitals and distributors across South Korea.
